For instance, the deletion of the gene encoding SREBP cleavage‐activating protein (SCAP) in the liver leads to liver damage, which manifests as nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) [4]. This evidence concerns the gene SCAP and metabolic dysfunction-associated steatohepatitis.